Modern ETF solutions for the next era of energy—join Amplify ETFs VP, Product Development and Management Nate Miller on this panel at @Vetta_Fi's Midyear Market Outlook Symposium: https://t.co/3D34s1USCc
Just launched! $SLJY, the Amplify $SILJ Covered Call ETF, targeting 18% annualized option premium income and capital appreciation. SLJY joins Amplify’s suite of YieldSmart™ ETFs: Smarter Options, Smarter Outcomes™: https://t.co/xMOU0CrhFf
Access Targeted 12% Option Premium Covered Call Strategy w/ $TLTP:
• High Income Potential
• Monthly Distribution Frequency
• Convenient Single Ticker
Amplify Bloomberg U.S. Treasury 12% Premium Income ETF (TLTP)
https://t.co/brdA6KNn58
@BBGIntelligence#income#stockmarket
Amplify ETFs is looking for energetic & result-driven individuals to join our team!
• Sr Marketing Mgr
• Marketing Assoc
• Senior Relationship Mgr
• Business Intelligence Mgr
• Product Development Assoc
Explore at https://t.co/zFIcgACoK7
#AmplifyYourCareer#ETFJobs#Jobs
Mark your calendars for the 4th annual Breakwave Day! Learn about global shipping markets (tankers & dry bulk) insights on December 5th, 10am-12pm EST 🚢🌊
https://t.co/ix6McpqMx4
#BreakwaveDay#ShippingInsights
New ETF! Access High Quality Small-Mid Cap Exposure via a Time-Tested Manager.
$SMAP: an actively managed strategy employing intensive fundamental & qualitative analysis to invest in high-quality small & mid-cap #growth and #value equity securities https://t.co/8yeIyrxJnv
#SMID
You're seeing the news on Merck & Co. ($MRK), but did you know it is a holding in $DIVO and $THNR?
For complete list of holdings and fund info:
Amplify CWP Enhanced Dividend Income ETF https://t.co/WBtl735kAp
Amplify Weight Loss Drug & Treatment ETF https://t.co/pmdNupwWxL
Goldman analysts updated the market growth forecast for Obesity therapeutics from $100bn to $130bn in 2030 and increased revenue forecasts for $LLY, the #1 holding in $THNR.
Learn more about $THNR, the first pure play obesity therapeutics index-based ETF https://t.co/2dDApxKzdo
Just launched! $THNR The first pure play index-based weight loss ETF.
Access companies pioneering the GLP-1 market. https://t.co/qLBhtSySQ0
#weightloss#glp1@EQMIndexes
The DEA is endorsing rescheduling. Discover what rescheduling may mean for the industry.
Greener Horizons: What is Happening with Cannabis Rescheduling.
https://t.co/KX7q62Wz6z
$CNBS $MJ $MJUS
Thank you @NYSE We were honored to ring Monday's opening bell with our partner, Samsung Asset Management to celebrate $SOF.
Learn more: https://t.co/StxHHCUWhu
#NYSE#BellRinging#investing#etfs
Exciting news out of Europe as Germany legalizes recreational use of #Cannabis effective today! Tune into the Cannabis Recap featuring $CNBS portfolio manager @timseymour for the latest on the markets and macro news in #cannabis.
Listen now: https://t.co/C9ccTgqEr3
$YYY current #yield is 11.99%, $HCOW is 7.88%, $NDIV is 5.89%, $IDVO is 6.02%, $SOF is 5.34% & $DIVO is 4.78% (as of 3/31/24). See table below.
Visit https://t.co/GJywRnmr7p for standardized performance and prospectuses.
@cwp_advisor, @KellyIntel, @EQMIndexes#income#ETFs